Glaucoma Specialist Jeffrey M. Liebmann Joins NewYork-Presbyterian/Columbia Ophthalmology

Share Article

Jeffrey M. Liebmann, MD, has been appointed vice-chair of the Department of Ophthalmology and professor of ophthalmology at Columbia University Medical Center and director of Glaucoma Services at NewYork-Presbyterian/Columbia University Medical Center. He will focus on expanding the clinical, research, and teaching programs in glaucoma.

Jeffrey M. Liebmann, MD, has been appointed vice-chair of the Department of Ophthalmology and professor of ophthalmology at Columbia University Medical Center and director of Glaucoma Services at NewYork-Presbyterian/Columbia University Medical Center. He will focus on expanding the clinical, research, and teaching programs in glaucoma. Dr. Liebmann most recently served as director of Glaucoma Services at Manhattan Eye, Ear, and Throat Hospital and NYU Langone Medical Center.

In addition to his clinical expertise, Dr. Liebmann brings a robust research program to NewYork-Presbyterian/Columbia that includes studies on the causes and risks of glaucoma, rate of progression, glaucoma surgery, ocular imaging, and neuroprotection. He is currently a principal investigator for two multicenter National Eye Institute clinical trials sponsored by the National Institutes of Health: the Ocular Hypertension Treatment Study and the African Descent and Glaucoma Evaluation Study. He will continue this work at Columbia.

“Dr. Liebmann's recruitment signifies our commitment to further develop excellence in every subspecialty within ophthalmology and is a game changer for our institutions,” said George Cioffi, MD, Jean and Richard Deems Professor of Ophthalmology, Edward S. Harkness Professor of Ophthalmology, chair of the Department of Ophthalmology at Columbia University College of Physicians and Surgeons, and ophthalmologist-in-chief at NewYork-Presbyterian/Columbia University Medical Center. “His outstanding work will be integrated into our current programs, providing a significant opportunity to rapidly advance our understanding of glaucoma and revolutionize the way it is detected and treated.”

Dr. Liebmann graduated from Boston University’s combined six-year medical education program in 1983; he completed his ophthalmology residency at the State University of New York/Downstate Medical Center and glaucoma fellowship training at the New York Eye and Ear Infirmary. He has authored or co-authored more than 450 publications and 1,000 abstracts, and he lectures extensively in the United States and abroad on glaucoma diagnosis, management, and research.

He is president of the World Glaucoma Association, past president of the American Glaucoma Society, secretary-treasurer of the New York Glaucoma Society, and coeditor of the Journal of Glaucoma. He is also a member of the board of governors of the World Glaucoma Association and the boards of directors of the Glaucoma Foundation and the American Glaucoma Society Foundation.

“Two to three percent of the population has glaucoma, but a larger proportion is at risk,” said Dr. Liebmann. “With longer life expectancies, the risk of visual impairment and blindness due to this disease is greatly increasing. The field of ophthalmology is going to see a lot of changes over the next few years, with a focus on using genetic information, risk factor assessment, and family history to target individuals at the greatest risk. These are the ‘big picture’ topics that we really want to tackle.”

Columbia University Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. For more information, visit cumc.columbia.edu or columbiadoctors.org.

NewYork-Presbyterian Hospital
NewYork-Presbyterian Hospital, based in New York City, is one of the nation’s largest and most comprehensive hospitals and a leading provider of inpatient, ambulatory and preventive care in all areas of medicine. With some 2,600 beds and more than 6,500 affiliated physicians and 20,000 employees, NewYork-Presbyterian had more than 2 million visits in 2013, including close to 15,000 infant deliveries and more than 310,000 emergency department visits. NewYork-Presbyterian comprises six campuses: NewYork-Presbyterian/Weill Cornell Medical Center, NewYork-Presbyterian/Columbia University Medical Center, NewYork-Presbyterian/Morgan Stanley Children's Hospital, NewYork-Presbyterian/The Allen Hospital, NewYork-Presbyterian/Westchester Division and NewYork-Presbyterian/Lower Manhattan Hospital. The hospital is also closely affiliated with NewYork-Presbyterian/Lawrence Hospital in Bronxville. NewYork-Presbyterian is the #1 hospital in the New York metropolitan area, according to U.S. News & World Report, and consistently named to the magazine’s Honor Roll of best hospitals in the nation. Affiliated with two world-renowned medical schools, Weill Cornell Medical College and Columbia University College of Physicians and Surgeons, NewYork-Presbyterian is committed to excellence in patient care, research, education and community service. For more information, visit http://www.nyp.org.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Jackie Shutack
NewYork-Presbyterian Hospital
+1 (212) 305-5587
Email >
Visit website